Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

D-0870 for AIDS-related oral candidiasis

June 13, 1997

Alfa Wassermann and Merckle sign development and marketing agreement for rifaximin

June 12, 1997

Successful phase III trials of Cytolex trigger milestone payment for Magainin

June 11, 1997

Peptidomimetic inhibitors of fungal NMT prepared by Searle

June 10, 1997

Micrologix Biotech enhancin restores activity of vancomycin

June 10, 1997

New antibacterial agents described by Zeneca

June 10, 1997

Generic aciclovir approved by FDA

June 9, 1997

In vitro activity of MEN-10700 assessed

June 5, 1997

3M to launch Aldara next week

June 5, 1997

Interferon Sciences announces distribution agreement for Alferon N Injection

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...